Table of contents

Clinical and epidemiological research

• Extended report: Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction (14 February, 2011) Free

  Daniel Aletaha, Julia Funovits, Josef S Smolen
• Extended report: Validation of a numerical rating scale to assess functional impairment in hip and knee osteoarthritis: comparison with the WOMAC function scale (13 December, 2010)

  Paul Ornetti, Maxime Dougados, Simon Paternotte, Isabelle Logeart, Laure Gossec
• Extended report: A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) (20 December, 2010)

  Pierre Quartier, Florence Allantaz, Rolando Cimaz, Pascal Pillet, Claude Messiaen, Christophe Bardin, Xavier Bossuyt, Anne Boutten, Jacques Bienvenu, Agnes Duquesne, Olivier Richer, Damien Chaussabel, Agnes Mogenet, Jacques Banchereau, Jean-Marc Treluyer, Paul Landais, Virginia Pascual
• Extended report: Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA) (27 December, 2010)

  Gerd R Burmester, E Feist, H Kellner, J Braun, C Iking-Konert, A Rubbert-Roth
• Extended report: Lupus Atherosclerosis Prevention Study (LAPS) (21 December, 2010)

  M A Petri, A N Kiani, W Post, L Christopher-Stine, L S Magder
• Extended report: Cardiac dysfunction in juvenile dermatomyositis: a case-control study (7 January, 2011)

  Thomas Schwartz, Helga Sanner, Trygve Husebye, Berit Flatø, Ivar Sjaastad
• Extended report: Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase (21 December, 2010)

  M G H van de Sande, M J H de Hair, C van der Leij, P L Klarenbeek, W H Bos, M D Smith, M Maas, N de Vries, D van Schaardenburg, B A C Dijkmans, D M Gerlag, P P Tak
• Extended report: Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial (27 December, 2010)

  Chi Chiu Mok, King Yee Ying, Chi Hung To, Ling Yin Ho, Ka Lung Yu, Hon Kit Lee, Kwok Man Ma
• Extended report: High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis (2 February, 2011)

  Karen Au, George Reed, Jeffrey R Curtis, Joel M Kremer, Jeffrey D Greenberg, Vibeke Strand, Daniel E Furst
• Extended report: Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments (17 January, 2011)

  Benazir Saleem, Andrew K Brown, Helen Keen, Sharmin Nizam, Jane Freeston, Richard Wakefield, Zunaid Karim, Mark Quinn, Elizabeth Hensor, Philip G Conaghan, Paul Emery
• Extended report: Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE) (13 February, 2011)

  M Dougados, J Braun, S Szanto, B Combe, M Elbaz, P Geher, G Thabut, V Leblanc, I Logeart
• Extended report: Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study (27 December, 2010)

  Ali Guermazi, Frank W Roemer, Daichi Hayashi, Michel D Crema, Jingbo Niu, Yuqing Zhang, Monica D Marra, Avinash Katur, John A Lynch, George Y El-Khoury, Kristin Baker, Laura B Hughes, Michael C Nevitt, David T Felson
• Extended report: Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study (2 February, 2011)

  Sella A Provan, Anne Grete Semb, Jonny Hisdal, Einar Stranden, Stefan Agewall, Hanne Dagfinrud, Kristin Angel, Dan Atar, Tore K Kvien
• Concise report: The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel (10 September, 2010)

  Gerd Burmester, Angel Lanas, Luigi Biasucci, Matthias Hermann, Stefan Lohmander, Ignazio Olivieri, Carmelo Scarpignato, Josef Smolen, Chris Hawkey, Adam Bajkowski, Francis Berenbaum, Ferdinand Breedveld, Peter Dieleman, Maxime Dougados, Thomas MacDonald, Emilio Martin Mola, Tony Mets, Nele Van Den Noortgate, Herman Stoevelaar
• Concise report: Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register (28 February, 2011)

  Suzanne M M Verstappen, Yvonne King, Kath D Watson, Deborah P M Symmons, Kimme L Hyrich, BSRBR Control Centre Consortium, BSR Biologics Register
• Concise report: A model for the development and implementation of a national plan for the optimal management of early spondyloarthritis: the Esperanza Program (17 January, 2011)

  Santiago Muñoz-Fernández, Loreto Carmona, Eduardo Collantes, Juan Mulero, M Jesús García-Yébenes, Eugenio de Miguel, Raquel Almodovar, Cristina Fernández-Carballido, José Francisco García Llorente, Milena Gobbo, the Esperanza Group